As described, mutations in SAMHD1 were recurrently found in CLL patients leading to reduced mRNA expression and in most cases, but not all, almost complete loss of SAMHD1 protein expression compared to B-cells (mRNA) or PBMCs (protein) from healthy donors [15]. The gene discussed is SAMHD1; the disease is B-cell chronic lymphocytic leukemia.